These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

27 related articles for article (PubMed ID: 4278529)

  • 1. Effect of dipyridamole on human platelet phospholipids.
    Aznar J; Valles J
    Experientia; 1976 May; 32(5):644-5. PubMed ID: 1278323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A "transport theory" for inhibition of platelet aggregation by adenosine.
    Holmsen H
    Acta Med Scand Suppl; 1971; 525():169-72. PubMed ID: 4260814
    [No Abstract]   [Full Text] [Related]  

  • 3. Proceedings: Binding of (14C) dipyradamole (RA 8) to platelets and inhibition of ADP induced platelet aggregation.
    Subbarao K; Rucinski B; Niewarowski S
    Thromb Diath Haemorrh; 1975 Nov; 34(2):552-3. PubMed ID: 1198424
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of dipyridamole and its monoglucuronide derivative on adenosine uptake by human platelets and ADP-induced platelet aggregation.
    Subbarao K; Rucinski B; Niewiarowski S
    Biochem Pharmacol; 1977 May; 26(9):906-7. PubMed ID: 861060
    [No Abstract]   [Full Text] [Related]  

  • 5. Cyclic GMP binding and phosphodiesterase: implication for platelet function.
    Hamet P; Coquil JF; Bousseau-Lafortune S; Franks DJ; Tremblay J
    Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 16():119-36. PubMed ID: 6202123
    [No Abstract]   [Full Text] [Related]  

  • 6. Mechanism of the antiplatelet action of dipyridamole in whole blood: modulation of adenosine concentration and activity.
    Gresele P; Arnout J; Deckmyn H; Vermylen J
    Thromb Haemost; 1986 Feb; 55(1):12-8. PubMed ID: 3704998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of dipyridamol on the electrokinetic potential of platelets.
    Aznar J; Vallés J
    Rev Esp Fisiol; 1974 Jun; 30(2):77-9. PubMed ID: 4278529
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical pharmacology of platelets.
    Packham MA; Mustard JF
    Blood; 1977 Oct; 50(4):555-73. PubMed ID: 332253
    [No Abstract]   [Full Text] [Related]  

  • 9. Antiplatelet agents: rationale and results.
    Kelton JG
    Clin Haematol; 1983 Feb; 12(1):311-54. PubMed ID: 6132693
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacology of platelet-suppressive agents.
    Wautier JL; Caen JP
    Semin Thromb Hemost; 1979; 5(4):293-315. PubMed ID: 386519
    [No Abstract]   [Full Text] [Related]  

  • 11. Platelets in glomerular disease.
    Cameron JS
    Annu Rev Med; 1984; 35():175-80. PubMed ID: 6372653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Common pathways of membrane reactivity after stimulation of platelets by different agents.
    Lüscher EF; Massini P
    Ciba Found Symp; 1975; 35():5-21. PubMed ID: 179771
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.